OVID - Ovid Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

OVID is currently covered by 1 analysts with an average price target of $8.34. This is a potential upside of $5.12 (159.01%) from yesterday's end of day stock price of $3.22.

Ovid Therapeutics's activity chart (see below) currently has 20 price targets and 16 ratings on display. The stock rating distribution of OVID is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.62% with an average time for these price targets to be met of 86 days.

Highest price target for OVID is $4, Lowest price target is $4, average price target is $8.34.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 25-May-2023. First documented stock forecast 09-Mar-2018.

Best performing analysts who are covering OVID - Ovid Therapeutics:

Yigal Nochomovitz Brian Abrahams Tyler Van Buren Charles Duncan

Currently out of the existing stock ratings of OVID, 4 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

4

$0.78 (24.22%)

2.5

10 months 19 days ago

8/14 (57.14%)

$0.61 (17.99%)

308

Buy

4

$0.16 (4.17%)

12

2 years 11 months 24 days ago

1/3 (33.33%)

$3.94 (76.95%)

36

Buy

5

3 years 1 months 10 days ago

0/2 (0%)

$2.06 (70.07%)

Buy

20

$16.53 (476.37%)

20

5 years 8 months 3 days ago

0/2 (0%)

$13.88 (226.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OVID (Ovid Therapeutics) average time for price targets to be met?

On average it took 86 days on average for the stock forecasts to be realized with a an average price target met ratio 22.62

Which analyst has the current highest performing score on OVID (Ovid Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the current lower performing score on OVID (Ovid Therapeutics) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?

Yigal Nochomovitz works at CITI and has 20 price targets and 14 ratings on OVID

Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?

Tyler Van Buren with highest potential upside - $16.53

Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?

Brian Abrahams with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?